Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RANY CONDOS

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1053302117
CMS profile
47830
Location
ASTORIA, NY

General Payments · PY2018–2024

$125,257.69

  • Reported across 210 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$17,295.45

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim Pharmaceuticals, Inc. $12,858.58 13
VERTEX PHARMACEUTICALS INCORPORATED $4,312.50 7
BAXTER HEALTHCARE $49.33 1
Acerta Pharma LLC $42.25 2
Insmed, Inc. $32.79 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $20,925.44 39
PY2019 $23,120.32 46
PY2020 $18,755.25 25
PY2021 $18,480.38 30
PY2022 $9,852.69 18
PY2023 $16,828.16 27
PY2024 $17,295.45 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $15.00 02/01/2024 Food and Beverage Undisputed 01/23/2026 1105721938 CMS
AstraZeneca Pharmaceuticals LP $27.25 09/30/2024 Food and Beverage Undisputed 01/23/2026 1105731497 CMS
Baxter Healthcare $49.33 10/30/2024 Food and Beverage Undisputed 01/23/2026 1120650645 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $11.80 03/15/2024 Food and Beverage Undisputed 01/23/2026 1117852307 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $122.43 06/26/2024 Food and Beverage Undisputed 01/23/2026 1117852319 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,700.00 07/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117852325 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.94 07/26/2024 Food and Beverage Undisputed 01/23/2026 1117852309 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $1,500.00 08/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117852323 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $120.18 09/17/2024 Food and Beverage Undisputed 01/23/2026 1117852315 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.67 10/25/2024 Food and Beverage Undisputed 01/23/2026 1117852313 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 10/30/2024 Food and Beverage Undisputed 01/23/2026 1117852321 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,700.00 11/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117852327 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,700.00 12/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117852305 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $2,700.00 12/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117852329 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $120.87 12/11/2024 Food and Beverage Undisputed 01/23/2026 1117852317 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.69 12/13/2024 Food and Beverage Undisputed 01/23/2026 1117852311 CMS
Insmed, Inc. $17.55 05/02/2024 Food and Beverage Undisputed 01/23/2026 1089572818 CMS
Insmed, Inc. $15.24 10/14/2024 Food and Beverage Undisputed 01/23/2026 1089559206 CMS
VERTEX PHARMACEUTICALS INCORPORATED $875.00 01/23/2024 Consulting Fee Undisputed 01/23/2026 1105912790 CMS
VERTEX PHARMACEUTICALS INCORPORATED $250.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1105908603 CMS
VERTEX PHARMACEUTICALS INCORPORATED $750.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1105912114 CMS
VERTEX PHARMACEUTICALS INCORPORATED $375.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1105912792 CMS
VERTEX PHARMACEUTICALS INCORPORATED $750.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1105912116 CMS
VERTEX PHARMACEUTICALS INCORPORATED $812.50 08/07/2024 Consulting Fee Undisputed 01/23/2026 1105909276 CMS
VERTEX PHARMACEUTICALS INCORPORATED $500.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 1105923153 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.